Treatment of Patients with Newly-Diagnosed Multiple Myeloma
Multiple Myeloma is an incurable disease. It is responsible for 1.8% of all cancers. The median age is 69–71 years. The treatment of MM is challenging and is affected by several factors such as the patient’s age, comorbidity index, and fitness. The main combination regimen consists of the addition o...
Guardado en:
| Autores principales: | , |
|---|---|
| Formato: | Capítulo de libro |
| Lenguaje: | inglés |
| Publicado: |
IntechOpen
2022
|
| Materias: | |
| Acceso en línea: | https://www.intechopen.com/chapters/82492 |
| Etiquetas: |
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares: Treatment of Patients with Newly-Diagnosed Multiple Myeloma
- Prognostic and Predictive Factors in Newly Diagnosed Multiple Myeloma Patients with Early Mortality with Prediction Matrix and Three and Five-Year Overall Survival
- Treatment Approaches of Multiple Myeloma
- Treatment of Multiple Myeloma in the First Relapse
- Proteasome Inhibitors in the Treatment of Multiple Myeloma
- Treatment and Disease-related Complications in Multiple Myeloma
- Quality of Life Issues of Patients with Multiple Myeloma